- March 20, 2024The Global CEO Initiative on Alzheimer’s Disease (CEOi) is excited to announce the second phase of its Blood-based Biomarker (BBM)…
- March 19, 2024CEOi held a blood-based biomarker symposium at the American Association for Geriatric Psychiatry (AAGP) 2024 Annual Meeting, “Unleashing Diagnostic Innovation:…